Minnesota Legislature
HF 1246
Status in the House for the 91st Legislature (2019 - 2020)
Revisor number: 19-3293
Description
Prescription Drug Price Transparency Act established, drug manufacturers required to submit drug price information to the commissioner of health, civil penalties provided, and report required.
Authors
Actions
House
| 02/14/2019 |
Introduction and first reading, referred to Health and Human Services Policy
|
| 02/18/2019 |
Authors added Munson and Xiong, J.
pg.
412
|
| 02/27/2019 | |
| 03/04/2019 |
Committee report, to adopt as amended and re-refer to Health and Human Services Policy
pg.
733a
|
| 03/11/2019 |
Committee report, to adopt and re-refer to Judiciary Finance and Civil Law Division
pg.
967
|
| 03/18/2019 |
Committee report, to adopt and re-refer to Ways and Means
pg.
1176
|
| 03/18/2019 |
Referred by Chair to Health and Human Services Finance Division
|
| 04/03/2019 |
Author added Sandstede
pg.
1837
|
| 04/10/2019 |
Author added Moller
pg.
3105
|
| 05/13/2019 |
Author added Hornstein
pg.
5801
|
| 02/20/2020 |
Author stricken Munson
pg.
6280
|
| 02/26/2020 |
Authors added Her, Noor, and Dehn
pg.
6507
|
| 02/27/2020 |
Division action, to adopt as amended and return to Ways and Means
|
| 03/11/2020 |
Committee report, without further rec to amend, re-refer to Judiciary Finance and Civil Law Division
pg.
6944a
|
| 04/17/2020 |
Author stricken McDonald
pg.
7217
|
| 04/28/2020 |
Committee report, to adopt and re-refer to Ways and Means
pg.
7226
|
| 04/28/2020 |
Joint rule 2.03, Deadlines, re-referred to Rules and Legislative Administration
pg.
7226
|
| 04/28/2020 |
Committee report, to adopt and re-refer to Ways and Means
pg.
7289
|
| 04/28/2020 |
Joint rule 2.03 waived
pg.
7289
|
| 05/04/2020 |
Author added Bernardy
pg.
7947
|
| 05/05/2020 |
Author stricken Gruenhagen
pg.
8000
|
| 05/11/2020 |
Author added Cantrell
pg.
8356
|
|
See Senate file in House SF1098
|